These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 11073856)

  • 21. Effect of recombinant soluble P-selectin glycoprotein ligand-1 on leukocyte-endothelium interaction in vivo. Role in rat traumatic shock.
    Scalia R; Hayward R; Armstead VE; Minchenko AG; Lefer AM
    Circ Res; 1999 Jan 8-22; 84(1):93-102. PubMed ID: 9915778
    [TBL] [Abstract][Full Text] [Related]  

  • 22. L- and P-selectins collaborate to support leukocyte rolling in vivo when high-affinity P-selectin-P-selectin glycoprotein ligand-1 interaction is inhibited.
    Ridger VC; Hellewell PG; Norman KE
    Am J Pathol; 2005 Mar; 166(3):945-52. PubMed ID: 15743805
    [TBL] [Abstract][Full Text] [Related]  

  • 23. New and effective treatment of experimentally induced venous thrombosis with anti-inflammatory rPSGL-Ig.
    Myers D; Wrobleski S; Londy F; Fex B; Hawley A; Schaub R; Greenfield L; Wakefield T
    Thromb Haemost; 2002 Mar; 87(3):374-82. PubMed ID: 11916067
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Administration of recombinant P-selectin glycoprotein ligand Fc fusion protein suppresses inflammation and neointimal formation in Zucker diabetic rat model.
    Zhou Z; Penn MS; Forudi F; Zhou X; Tarakji K; Topol EJ; Lincoff AM; Wang K
    Arterioscler Thromb Vasc Biol; 2002 Oct; 22(10):1598-603. PubMed ID: 12377736
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The inhibitory role of recombinant P-selectin glycoprotein ligand immunoglobulin G on portal vein thrombosis based on a novel rat model.
    Wei Y; Shao J; Shen H; Wang Y; Cao G; Chen W; Zhang J; Yin L
    Exp Ther Med; 2019 May; 17(5):3589-3597. PubMed ID: 30988741
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacokinetics, pharmacodynamics, allometry, and dose selection of rPSGL-Ig for phase I trial.
    Khor SP; McCarthy K; DuPont M; Murray K; Timony G
    J Pharmacol Exp Ther; 2000 May; 293(2):618-24. PubMed ID: 10773036
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Early events in the formation of a venous thrombus following local trauma and stasis.
    Schaub RG; Simmons CA; Koets MH; Romano PJ; Stewart GJ
    Lab Invest; 1984 Aug; 51(2):218-24. PubMed ID: 6748615
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibition of factor XI reduces thrombus formation in rabbit jugular vein under endothelial denudation and/or blood stasis.
    Takahashi M; Yamashita A; Moriguchi-Goto S; Sugita C; Matsumoto T; Matsuda S; Sato Y; Kitazawa T; Hattori K; Shima M; Asada Y
    Thromb Res; 2010 May; 125(5):464-70. PubMed ID: 20089298
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prophylactic P-selectin inhibition with PSI-421 promotes resolution of venous thrombosis without anticoagulation.
    Meier TR; Myers DD; Wrobleski SK; Zajkowski PJ; Hawley AE; Bedard PW; Ballard NE; Londy FJ; Kaila N; Vlasuk GP; Schaub RG; Wakefield TW
    Thromb Haemost; 2008 Feb; 99(2):343-51. PubMed ID: 18278184
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Recombinant soluble P-selectin glycoprotein ligand-1 protects against myocardial ischemic reperfusion injury in cats.
    Hayward R; Campbell B; Shin YK; Scalia R; Lefer AM
    Cardiovasc Res; 1999 Jan; 41(1):65-76. PubMed ID: 10325954
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Platelets modulate ischemia/reperfusion-induced leukocyte recruitment in the mesenteric circulation.
    Salter JW; Krieglstein CF; Issekutz AC; Granger DN
    Am J Physiol Gastrointest Liver Physiol; 2001 Dec; 281(6):G1432-9. PubMed ID: 11705748
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Reduction of hepatic ischemia/reperfusion injury by a soluble P-selectin glycoprotein ligand-1.
    Dulkanchainun TS; Goss JA; Imagawa DK; Shaw GD; Anselmo DM; Kaldas F; Wang T; Zhao D; Busuttil AA; Kato H; Murray NG; Kupiec-Weglinski JW; Busuttil RW
    Ann Surg; 1998 Jun; 227(6):832-40. PubMed ID: 9637546
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Recombinant P-selectin glycoprotein ligand-immunoglobulin, a P-selectin antagonist, as an adjunct to thrombolysis in acute myocardial infarction. The P-Selectin Antagonist Limiting Myonecrosis (PSALM) trial.
    Mertens P; Maes A; Nuyts J; Belmans A; Desmet W; Esplugas E; Charlier F; Figueras J; Sambuceti G; Schwaiger M; Mortelmans L; Van de Werf F;
    Am Heart J; 2006 Jul; 152(1):125.e1-8. PubMed ID: 16824841
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Decrease in fibrin content of venous thrombi in selectin-deficient mice.
    Sullivan VV; Hawley AE; Farris DM; Knipp BS; Varga AJ; Wrobleski SK; Thanapron P; Eagleton MJ; Myers DD; Fowlkes JB; Wakefield TW
    J Surg Res; 2003 Jan; 109(1):1-7. PubMed ID: 12591228
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CD62 blockade with P-Selectin glycoprotein ligand-immunoglobulin fusion protein reduces ischemia-reperfusion injury after rat intestinal transplantation.
    Farmer DG; Shen XD; Amersi F; Anselmo D; Ma JP; Ke B; Gao F; Dry S; Fernandez S; Shaw GD; McDiarmid SV; Busuttil RW; Kupiec-Weglinski J
    Transplantation; 2005 Jan; 79(1):44-51. PubMed ID: 15714168
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Capture of platelets to the endothelium of the femoral vein is mediated by CD62P and CD162.
    Slotta JE; Braun OO; Menger MD; Thorlacius H
    Platelets; 2009 Nov; 20(7):505-12. PubMed ID: 19852690
    [TBL] [Abstract][Full Text] [Related]  

  • 37. P-selectin dependent targeting to inflamed endothelium of recombinant P-selectin glycoprotein ligand-1 immunoglobulin chimera-coated poly[N-(2-hydroxypropyl) methacrylamide]-DNA polyplexes in vivo visualised by intravital microscopy.
    Newman CM; Crosdale DJ; Fisher KD; Briggs SS; Norman KE; Seymour LW; Hellewell PG
    J Gene Med; 2009 Apr; 11(4):326-34. PubMed ID: 19219895
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Recombinant soluble P-selectin glycoprotein ligand 1 moderates local and remote injuries following experimental lower-torso ischaemia.
    Kyriakides C; Favuzza J; Wang Y; Austen WG; Moore FD; Hechtman HB
    Br J Surg; 2001 Jun; 88(6):825-30. PubMed ID: 11412252
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Endothelial PPAR-γ protects against vascular thrombosis by downregulating P-selectin expression.
    Jin H; Gebska MA; Blokhin IO; Wilson KM; Ketsawatsomkron P; Chauhan AK; Keen HL; Sigmund CD; Lentz SR
    Arterioscler Thromb Vasc Biol; 2015 Apr; 35(4):838-44. PubMed ID: 25675995
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Diminished thrombus formation and alleviation of myocardial infarction and reperfusion injury through antibody- or small-molecule-mediated inhibition of selectin-dependent platelet functions.
    Oostingh GJ; Pozgajova M; Ludwig RJ; Krahn T; Boehncke WH; Nieswandt B; Schön MP
    Haematologica; 2007 Apr; 92(4):502-12. PubMed ID: 17488661
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.